A168 USE OF LEDIPASVIR/SOFOSBUVIR (LDV/SOF) WITH OR WITHOUT RIBAVIRIN (RBV) IN GENOTYPE 1 (GT 1) HCV-INFECTED PATIENTS POST LIVER TRANSPLANT (LT): EVALUATION OF SEVERAL REAL-WORLD DATASETS (RWD)

AIMS: Post LT patients infected with HCV are considered a hard-to-treat population. The FDA and Health Canada have recently approved treatment with LDV/SOF+RBV in GT1 LT recipients ± compensated liver disease based on SOLAR-1 & -2 data. Recent reports have shown that SVR rates achieved in HCV mo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Bourliere, M, Charlton, M, Manns, M, Prieto, M, Fernandez, I, Londoño, M, Kwok, R, Smith, C, Ngo, H, Lee, S, Zhang, J, Arterburn, S, Copans, A, Rosarro, L, Curry, M, Flamm, S
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507581/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados